Penumbra (PEN) Revenue Growth (1y) (2015 - 2026)
Penumbra (PEN) Revenue Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 6.08% |
| 10 | Penumbra | 12.58 Bn | 11.97 Bn | 253.41 Mn | 15.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.62% |
| Dec 31, 2025 | 22.14% |
| Sep 30, 2025 | 17.82% |
| Jun 30, 2025 | 13.38% |
| Mar 31, 2025 | 16.32% |
| Dec 31, 2024 | 10.83% |
| Sep 30, 2024 | 11.11% |
| Jun 30, 2024 | 14.49% |
| Mar 31, 2024 | 15.43% |
| Dec 31, 2023 | 28.69% |
| Sep 30, 2023 | 26.80% |
| Jun 30, 2023 | 25.51% |
| Mar 31, 2023 | 18.39% |
| Dec 31, 2022 | 8.43% |
| Sep 30, 2022 | 12.39% |
| Jun 30, 2022 | 13.07% |
| Mar 31, 2022 | 20.50% |
| Dec 31, 2021 | 22.24% |
| Sep 30, 2021 | 25.84% |
| Jun 30, 2021 | 75.30% |